Stuff that occurs to me

All of my 'how to' posts are tagged here. The most popular posts are about blocking and private accounts on Twitter, also the science communication jobs list. None of the science or medical information I might post to this blog should be taken as medical advice (I'm not medically trained).

Think of this blog as a sort of nursery for my half-baked ideas hence 'stuff that occurs to me'.

Contact: @JoBrodie Email: jo DOT brodie AT gmail DOT com

Science in London: The 2018/19 scientific society talks in London blog post

Showing posts with label research process. Show all posts
Showing posts with label research process. Show all posts

Monday, 3 August 2015

Blunt tool idea: colour-coded system for medical research papers' study design, and conclusions

Yesterday I tweeted this
I was pleasantly surprised that no-one laughed and it even got a few retweets, and a later 'bump' tweet resulted in a bit of discussion with Jon Mendel and Adam Jacobs on the practicalities.

A great deal of research is about getting your bearings - something looks interesting to study and so people chip away at it. This is fine. What's problematic is when someone reads what's essentially a compass reading pointing North-ish and announces that a paper is evidence that we're at the North Pole. I had the idea that some sort of colour scheme might have one colour to indicate that Paper X is a well-designed meta-analysis and conclusions are reasonably firm and a different colour for Paper Y which reports on a small observational study that, while perfectly well designed on its own, cannot support such strong conclusions.

My blog is littered with ideas that sound great (to me) in theory but are a bit unimplentable and I suspect that this may be one of them but after I managed (top-of-the-head idea mine, actual effort in making it happen was @McDawg) to get share-buttons on PubMed I've become drunk on my own success ;)

Discussions with Jon and Adam considered whereabouts in the publication cycle this colour scheme might be employed. Authors might not be keen to have a 'lower grade' of colour, editors might not agree on the colour scheme (think food manufacturers and the traffic light system for fats and salt etc). My thinking is that it would happen post-publication, if at all.

Background
Making sense of medical research abstracts involves a variety of types of knowledge, even when the abstract's telling you stuff there are things you already need to know. Those things might include physiological facts (knowing that gastric refers to the stomach and not the leg) but perhaps more likely to trip someone up is the specialist background knowledge needed to know if the study's conclusions - or a newspaper's conclusions - can be drawn from the method.

A simple example is a study that gives 500 people a pill and measures what happens. This doesn't really confirm that any effects were due to the pill. You probably need a control group and it might be helpful to randomly assign trial participants into the 'get pill' and 'not get pill' groups. The plan is to try and compare two similar groups and make the presence or absence of the pill the only difference.

My experience of people not knowing enough about study design (and the conclusions that can reasonbly be drawn) comes from several domains.

1. People who have a health condition and want to find out about the latest research. 
These are very motivated people who often do learn a lot about research methods but I've spoken to a lot of people (in my former capacity as science info officer at a health charity) who floundered a bit. Similarly not everyone working in a health charity is confident about trial design (I nearly always had to look stuff up myself!) so a few pointers might be helpful here. I've expanded on this in a much earlier post: Might #AcademicSpring change the way in which journal articles (esp medical) are written?  (11 April 2012)

2. Newspaper reports
#NotAllNewspaperReports of course, and sometimes the text is fine but the headline lets it down. However there are plenty of newspaper reports that imply that something is more certain than it is and people are confused and misinformed.

3. Homeopathy advocates
Anyone who keeps an eye on the #homeopathy hashtag will see supporters of homeopathy adding links to various PubMed abstracts in their tweets and stating or implying that the paper proves that homeopathy is not a load of twaddle. These are often very small studies, no control group, or insufficient information about what other treatments people were having alongside. The abstracts are not strong enough to support some of the conclusions advocates make for them.




Tuesday, 19 August 2014

Currently blithering about: a science communication / public engagement continuum, possibly spiral

Science communication and public engagement are overlapping things that I'm involved in to various degrees.

When I worked at Diabetes UK one of my roles was to answer medical* / science enquiries from members of the public (and colleagues). For example "why shouldn't I drink grapefruit juice if I'm taking statins?", "why can't you just transplant beta cells from an identical twin in someone with type 1 diabetes?", "will taking these herbal pills cure my diabetes?", "how many people have [this complication] in [City / UK]?" etc.

*not giving medical advice as not qualified to give any!

While providing this service certainly counts as engaging with the public to a degree I never really thought of it as public engagement in a classic sense and more along the lines of 'educating' people for want of a better word. They rang up asking for info and we did our best to provide it.

As an organisation we did other more 'engagey' things - people with diabetes were involved in the decision-making about what research we'd fund (they were on the research committee along with scientists, psychologists etc), we liaised with the UK Diabetes Research Network to share opportunities for people to get involved as participants in research and we gave talks to groups about our research (again, more 'informing').

The work I do on CHI+MED is a bit of both - I write stuff for our website and blog which hopefully informs people about what we've been up to, but I'm also involved in 'co-ordinating' the public engagement work of colleagues who are directly involving people (sometimes patients) in research, as well as stakeholders.

You can imagine researchers doing a piece of research and then, once finished, publishing it in an academic journal ... and then telling journalists about it via press releases or appearances on TV or in newspapers etc. While there's nothing particularly wrong with this many universities are trying to involve / engage people in research a bit earlier.

But even this 'informing about outputs already achieved' (ie it's now too late for any opportunity to 'feed in') presumably counts towards sparking interest and getting people involved in the researchers' next project...Possi

I have been mulling over the idea of a continuum. I rejected an oval shaped thing where you start with research being done and go to research being published academically with a line taking you back to the beginning and am instead thinking of something that's more of a spiral (it goes back to the beginning but of the next research project).

Then I asked Twitter and got lots of interesting and helpful replies (now added at the end), and a whole load of things to read - Twitter is rather good at helping you avoid reinventing the wheel!

But despite this - here is my draft wheel for everyone to poke fun at and go "no you've got it wrong". This is because I'm involving you in my 'research' here :)































The above is a slide that I'm probably not even going to use in a talk I'm giving in a couple of weeks for CHI+MED, but I needed something concrete to help me put the talk together and to talk about different stages and audiences for our work.

As I see it, research happens (the 'Research is done' to 'Research is published in academic journals' (#1) and there are opportunities for the public to feed in, alongside scientists, politicians, others to determine what research should be funded (#2) and opportunities to be participants in research. This can be participating in a clinical trial, or co-designing a product etc. At the 'end' of the research the academic output often finds its way into other media as well (#3) and it often finds its way there at earlier stages in the research too.

The continuum-y bit (#4) where a black arrow goes back to the start is a bit confusing cos it's obviously not going back in time (research has been done) but possibly feeds into later projects. So it's more of a Science Communication Spiral.

Aren't you glad I didn't try and express this in a Venn diagram :)

Helpful replies from chums on Twitter










and Jon Mendel also wrote critically about the 'Science: So What? So Everything' campaign of science communication